Paper
28 August 2023 Identification of natural products as dual sphingosine kinase-1 and programmed cell-death 1-inhibitors by virtual screening and molecular dynamics simulation
Jin Liu, Huilin Zhao, Lei He, Rilei Yu, Congmin Kang
Author Affiliations +
Proceedings Volume 12724, Second International Conference on Biomedical and Intelligent Systems (IC-BIS 2023); 1272405 (2023) https://doi.org/10.1117/12.2687726
Event: Second International Conference on Biomedical and Intelligent Systems (IC-BIS2023), 2023, Xiamen, China
Abstract
Anti-PD-1 have demonstrated significant clinical efficacy in tumor by reversing T-cell dysfunction and exhaustion, therapy enhancing anti-tumoral properties. However, the overall response rate of anti-PD-1 is not high, and responder experience tumor relapse within 2 years. The combination of targeting sphingosine kinase-1 and programmed cell death 1 as a potential therapy way to overcome the problems of immune checkpoint resistance and non-response. Therefore, the primary goal of this study was to discovery natural compounds for dual targeting sphingosine kinase-1 and programmed cell death 1 ligand 1. A natural product database was constructed, and ADMET was used to evaluate natural products for primary screening. Molecular docking and Molecular Mechanics/Generalized Born Surface Area found candidate natural products, three natural products docking conformation were performed 100 ns molecular dynamics simulation. Natural compound 2, 3, 4 have further study value as dual targeting Sphk1 and PD-1 inhibitors.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jin Liu, Huilin Zhao, Lei He, Rilei Yu, and Congmin Kang "Identification of natural products as dual sphingosine kinase-1 and programmed cell-death 1-inhibitors by virtual screening and molecular dynamics simulation", Proc. SPIE 12724, Second International Conference on Biomedical and Intelligent Systems (IC-BIS 2023), 1272405 (28 August 2023); https://doi.org/10.1117/12.2687726
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Molecules

Resistance

Proteins

RELATED CONTENT

Recent research progress on the role of BCL2 in cancer...
Proceedings of SPIE (March 24 2023)
CRISPR-Cas9 system applications in cancer models
Proceedings of SPIE (March 24 2023)
Regulation and therapeutic applications of autophagy in cancer
Proceedings of SPIE (September 07 2023)
Quantitative fluorescence nanoscopy for cancer biomedicine
Proceedings of SPIE (August 21 2015)
Transport modalities of photodynamic agents for tumors
Proceedings of SPIE (March 01 1994)
Clinical application of proteolysis targeting chimeras
Proceedings of SPIE (September 07 2023)

Back to Top